These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 21536074

  • 1. Novel monoclonal antibodies that bind to wild and fixed rabies virus strains.
    Zanluca C, Aires LR, Mueller PP, Santos VV, Carrieri ML, Pinto AR, Zanetti CR.
    J Virol Methods; 2011 Jul; 175(1):66-73. PubMed ID: 21536074
    [Abstract] [Full Text] [Related]

  • 2. Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants.
    Bakker AB, Marissen WE, Kramer RA, Rice AB, Weldon WC, Niezgoda M, Hanlon CA, Thijsse S, Backus HH, de Kruif J, Dietzschold B, Rupprecht CE, Goudsmit J.
    J Virol; 2005 Jul; 79(14):9062-8. PubMed ID: 15994800
    [Abstract] [Full Text] [Related]

  • 3. Binding properties of monoclonal antibodies to rabies virus.
    Cusi MG, Valensin PE, Tollis M, Bracci L, Petreni S, Soldani P.
    Microbiologica; 1991 Jul; 14(3):205-11. PubMed ID: 1921740
    [Abstract] [Full Text] [Related]

  • 4. G glycoprotein amino acid residues required for human monoclonal antibody RAB1 neutralization are conserved in rabies virus street isolates.
    Wang Y, Rowley KJ, Booth BJ, Sloan SE, Ambrosino DM, Babcock GJ.
    Antiviral Res; 2011 Aug; 91(2):187-94. PubMed ID: 21693135
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Development and characterization of neutralizing monoclonal antibodies against the pandemic H1N1 virus (2009).
    Cabral TM, Berhane Y, Schmidt L, Tracz DM, Hole K, Leith M, Corbett CR.
    J Virol Methods; 2012 Jul; 183(1):25-33. PubMed ID: 22575685
    [Abstract] [Full Text] [Related]

  • 8. Monoclonal antibodies which recognize the acidic configuration of the rabies glycoprotein at the surface of the virion can be neutralizing.
    Raux H, Coulon P, Lafay F, Flamand A.
    Virology; 1995 Jul 10; 210(2):400-8. PubMed ID: 7542418
    [Abstract] [Full Text] [Related]

  • 9. Common and different antigenic properties of the rabies virus glycoprotein of strains SAD-Vnukovo and Pitman-Moore.
    Máciková I, Dedek L, Vrzal V, Kontseková E, Kontsek P, Ciampor F, Novák M.
    Acta Virol; 1992 Dec 10; 36(6):541-50. PubMed ID: 1284868
    [Abstract] [Full Text] [Related]

  • 10. Conformation-dependent accessibility of the linear epitopes located on the rabies virus glycoprotein.
    Kontsekova E, Macikova I, Novak M, Dedek L, Vrzal V, Kontsek P.
    Viral Immunol; 1992 Dec 10; 5(3):213-20. PubMed ID: 1418319
    [Abstract] [Full Text] [Related]

  • 11. Isolation and characterization of novel human monoclonal antibodies possessing neutralizing ability against rabies virus.
    Matsumoto T, Yamada K, Noguchi K, Nakajima K, Takada K, Khawplod P, Nishizono A.
    Microbiol Immunol; 2010 Nov 10; 54(11):673-83. PubMed ID: 21044141
    [Abstract] [Full Text] [Related]

  • 12. Engineering of a recombinant trivalent single-chain variable fragment antibody directed against rabies virus glycoprotein G with improved neutralizing potency.
    Turki I, Hammami A, Kharmachi H, Mousli M.
    Mol Immunol; 2014 Feb 10; 57(2):66-73. PubMed ID: 24091293
    [Abstract] [Full Text] [Related]

  • 13. Use of anti-glycoprotein monoclonal antibodies to characterize rabies virus in formalin-fixed tissues.
    Warner C, Fekadu M, Whitfield S, Shaddock J.
    J Virol Methods; 1999 Jan 10; 77(1):69-74. PubMed ID: 10029326
    [Abstract] [Full Text] [Related]

  • 14. Mechanisms of rabies virus neutralization.
    Flamand A, Raux H, Gaudin Y, Ruigrok RW.
    Virology; 1993 May 10; 194(1):302-13. PubMed ID: 7683158
    [Abstract] [Full Text] [Related]

  • 15. Production and characterization of monoclonal antibodies against avian reovirus strain S1133.
    Li L, Giambrone JJ, Panangala VS, Hoerr FJ.
    Avian Dis; 1996 May 10; 40(2):349-57. PubMed ID: 8790885
    [Abstract] [Full Text] [Related]

  • 16. Generation and characterization of neutralizing human recombinant antibodies against antigenic site II of rabies virus glycoprotein.
    Sun L, Chen Z, Yu L, Wei J, Li C, Jin J, Shen X, Lv X, Tang Q, Li D, Liang M.
    Appl Microbiol Biotechnol; 2012 Oct 10; 96(2):357-66. PubMed ID: 22678022
    [Abstract] [Full Text] [Related]

  • 17. Generation and characterization of human monoclonal antibodies to G5, a linear neutralization epitope on glycoprotein of rabies virus, by phage display technology.
    Zhao XL, Yin J, Chen WQ, Jiang M, Yang G, Yang ZH.
    Microbiol Immunol; 2008 Feb 10; 52(2):89-93. PubMed ID: 18380806
    [Abstract] [Full Text] [Related]

  • 18. Novel rabies virus-neutralizing epitope recognized by human monoclonal antibody: fine mapping and escape mutant analysis.
    Marissen WE, Kramer RA, Rice A, Weldon WC, Niezgoda M, Faber M, Slootstra JW, Meloen RH, Clijsters-van der Horst M, Visser TJ, Jongeneelen M, Thijsse S, Throsby M, de Kruif J, Rupprecht CE, Dietzschold B, Goudsmit J, Bakker AB.
    J Virol; 2005 Apr 10; 79(8):4672-8. PubMed ID: 15795253
    [Abstract] [Full Text] [Related]

  • 19. Development and application of monoclonal antibodies against avian influenza virus nucleoprotein.
    Yang M, Berhane Y, Salo T, Li M, Hole K, Clavijo A.
    J Virol Methods; 2008 Feb 10; 147(2):265-74. PubMed ID: 18006085
    [Abstract] [Full Text] [Related]

  • 20. Development of human monoclonal antibodies to rabies.
    Dorfman N, Dietzschold B, Kajiyama W, Fu ZF, Koprowski H, Notkins AL.
    Hybridoma; 1994 Oct 10; 13(5):397-402. PubMed ID: 7860096
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.